Social forestry expenditure requires activity-based classification, limiting book-profit adjustments and preserving penalty relief where normal additi...
Inaccurate-particulars penalties fail where transfer-pricing documentation shows good faith and due diligence, and underlying capital-gains additions ...
Transfer-pricing tolerance for software sub-licensing falls within the services range, eliminating the adjustment and requiring TDS-credit verificatio...
Bulk drugs and active pharmaceutical ingredients qualify as "All Drugs and medicines" for concessional IGST treatment where they meet the drug description and are not within the prescribed nil-rate exclusion. The statutory drug definition includes substances intended for use as drug components; importing APIs for testing, clinical research, clinical trials, bioavailability, or bioequivalence studies does not alone change that status. The drugs-and-medicines entry applies across tariff chapters and prevails over general Chapter 28 or 29 chemical entries under the specific-over-general classification principle. Qualifying APIs attract IGST at 5%, subject to examination of the exclusion for each imported product.
Bulk drugs and active pharmaceutical ingredients qualify as "All Drugs and medicines" for concessional IGST treatment where they meet the drug description and are not within the prescribed nil-rate exclusion. The statutory drug definition includes substances intended for use as drug components; importing APIs for testing, clinical research, clinical trials, bioavailability, or bioequivalence studies does not alone change that status. The drugs-and-medicines entry applies across tariff chapters and prevails over general Chapter 28 or 29 chemical entries under the specific-over-general classification principle. Qualifying APIs attract IGST at 5%, subject to examination of the exclusion for each imported product.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4879 
